Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ: IOVA )

3.500 -0.320 (-8.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Iovance Biotherapeutics, inc (IOVA) Q3 2021 Earnings Call Transcript
IOVA earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
Exposures COVID-19
Why Iovance Biotherapeutics' Stock Is Trading Higher Today
Iovance Biotherapeutics (NASDAQ:IOVA) shares are... 
Via Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Corvus Pharmaceuticals (NASDAQ:CRVS 
Via Benzinga
Why Iovance Is Up Nearly 11% Today
Investors are starting to connect some drug development dots... with a little help. 
Via The Motley Fool
Cathie Wood's Ark ETFs Underperformed The Broader Market In Q2, With Workhorse, Virgin Galactic, Coinbase, Teladoc Taking Big Toll
ARK Invest, the New York-based investment management firm led by the popular money manager Cathie Wood, saw its five actively managed exchange-traded funds and two self-indexed... 
Via Benzinga
Why Iovance Biotherapeutics Soared 40% In June
The biopharma outfit has put some red flags in the rearview mirror, and sees a plausible approval on the horizon. 
Via The Motley Fool
June’s Best and Worst Performing Russell 1,000 Stocks
The month of June, the second quarter and the first half of 2021 are almost in the bag. 
Via Talk Markets
Iovance Biotherapeutics' TIL Therapy Achieves ORR Of 21.4% In Pre-Treated Lung Cancer Patients
Iovance Biotherapeutics Inc (NASDAQ: IOVA) has announced clinical data for its tumor-infiltrating lymphocyte (TIL) therapy LN-145 in patients with metastatic non-... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) shares moved upwards by 42.0% to $17.85 during Tuesday's pre-market session. The company's market cap stands at $2.... 
Via Benzinga
Should You Buy This Cathie Wood Biotech Stock?
This biotech's fumble has caught the attention of a fund manager known for making innovative investments. 
Via The Motley Fool
Best and Worst Russell 1000 Stocks So Far in June
Right at the midpoint of June, Biogen has been the top-performing Russell 1,000 stock month to date. 
Via Talk Markets
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares... 
Via Benzinga
Iovance's Lifileucel Shows Meaningful Increase in Response Time with Primary Anti-PD-1 Resistance in Melanoma Trial
Iovance Biotherapeutics Inc (NASDAQ: IOVA) announced updated clinical data for lifileucel from Cohort 2 of C-144-01 clinical study in patients with advanced melanoma. Data... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Cellect Biotechnology (NASDAQ:APOP 
Via Benzinga
Most of ARKK Bouncing But Still Down Big
After trading deep into oversold territory, the past two weeks have seen the ARK Innovation ETF erase some of the losses of the past few months. 
Via Talk Markets
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... 
Via Benzinga
Exposures Product Safety
10 Biggest Price Target Changes For Monday
Morgan Stanley raised Deere & Company (NYSE: DE) price target from $410 to $450. Deere shares rose 0.4% to $361.00 in pre-market trading. Oppenheimer cut Iovance... 
Via Benzinga
Why Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)
Cathie Wood-led Ark Investment Management is betting that despite recent setbacks Iovance Biotherapeutics Inc (NASDAQ: IOVA) will benefit from its compelling tumor-... 
Via Benzinga
Cathie Wood Loads Up Yet Another $51M In Coinbase As Shares Slump Amid Bitcoin-Led Crypto Carnage
Cathie Wood-led Ark Investment Management on Friday snapped up another 223,181 shares, worth about $50.7 million, in Coinbase Global Inc 
Via Benzinga
Here's Why Everyone's Talking About Iovance Biotherapeutics
The CEO's unexplained departure has left investors scratching their heads. 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers PDS Biotechnology (NASDAQ:PDSB) shares increased by 18.99% to $6.83 during Thursday's regular session. PDS Biotechnology's stock is trading at a volume of... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday. Urban One, Inc. (NASDAQ: UONE) gained 59.1% to close at $9.56. Urban... 
Via Benzinga
Iovance Shares Jump After Lifileucel Achieves 86% Response Rate In Melanoma Trial
Yesterday the FDA asked Iovance Biotherapeutics Inc (NASDAQ: IOVA) for more data on the assays for lifileucel US application. Now the company announced ... 
Via Benzinga
Exposures Product Safety
38 Stocks Moving In Thursday's Mid-Day Session
Gainers Newegg Commerce Inc. (NASDAQ: NEGG) shares jumped 30% to $12.03. Precipio, Inc. (NASDAQ: PRPO) gained 22.3% to $5.05. Precipio recently announced it launched a new, four-... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2021
Upgrades According to Argus Research, the prior rating for Vontier Corp (NYSE:VNT) was changed from Hold to Buy. In the first quarter, Vontier earned $0.63. At the moment... 
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) ESSA Pharma Inc. (NASDAQ:... 
Via Benzinga
Exposures COVID-19
10 Biggest Price Target Changes For Thursday
Keybanc lowered the price target on Micron Technology, Inc. (NASDAQ: MU) from $137 to $115. Micron shares fell 0.1% to $79.88 in pre-market trading. Goldman Sachs cut SolarEdge... 
Via Benzinga
50 Biggest Movers From Yesterday
Gainers MoSys, Inc. (NASDAQ: MOSY) shares jumped 44.1% to settle at $5.46 on Wednesday. Lianluo Smart Limited (NASDAQ: LLIT) gained 24.6% to settle at $9.22. Reata... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.